Co-Authors
This is a "connection" page, showing publications co-authored by Dao Wang and Jian-Ping Zuo.
Connection Strength
0.292
-
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial. Front Med. 2021 Oct; 15(5):704-717.
Score: 0.236
-
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020 Sep; 41(9):1167-1177.
Score: 0.056